A coalition of 86 organizations is urging Congress to pass the Clinical Treatment Act, a bill introduced in January that would guarantee coverage of the routine care costs of clinical trial participation for Medicaid patients with a life-threatening condition.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
